✨ Free AI Report
Gulf Pharmaceutical Industries P.S.C.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Gulf Pharmaceutical Industries P.S.C.
Company Research

Gulf Pharmaceutical Industries P.S.C.: Business Overview, Financials & Competitive Analysis

Gulf Pharmaceutical Industries P.S.C. scores 6/10 on the AskCyborg Cyborg Score (Solid). Profitable UAE pharma operator with strong liquidity and recovering financial performance trading below industry valuation multiples. Strong financial turnaround with net income of AED 166.7 million in 9M 2025. Well-managed debt and high earnings quality offset concerns of low ROE at 6.5% and high share price volatility.

What is Gulf Pharmaceutical Industries P.S.C.'s industry? Gulf Pharmaceutical Industries P.S.C. (julphar.net) operates in Pharmaceutical Manufacturing & Healthcare Products. AskCyborg classifies Gulf Pharmaceutical Industries P.S.C. under Pharmaceutical Manufacturing & Healthcare Products in its company registry.

Gulf Pharmaceutical Industries manufactures and sells medicines, injections, and consumer healthcare products with specialization in wound care, cardiovascular, diabetes solutions, and pain management. The company ope...

6/ 10Solid

Cyborg Score thesis

Profitable UAE pharma operator with strong liquidity and recovering financial performance trading below industry valuation...

Read the full analyst-debate transcript →
Industry Pharmaceutical Manufacturing & Healthcare Products
1 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Gulf Pharmaceutical Industries P.S.C. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Gulf Pharmaceutical Industries P.S.C.

AskCyborg analysts argue the bull and bear cases for Gulf Pharmaceutical Industries P.S.C. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Gulf Pharmaceutical Industries P.S.C. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Gulf Pharmaceutical Industries P.S.C. Overview

Pro stress-test →

Gulf Pharmaceutical Industries manufactures and sells medicines, injections, and consumer healthcare products with specialization in wound care, cardiovascular, diabetes solutions, and pain management. The company operates through a network of more than 10 manufacturing plants and maintains approximately 800 products in various dosage forms.

Strategic Profile

Pro stress-test →

The company has demonstrated a strong financial turnaround, becoming profitable with net income reaching AED 166.7 million for the first nine months of 2025. Short-term assets comfortably cover both short and long-term liabilities while debt levels are well-managed with a satisfactory net debt to equity ratio of 1%. The company's P/E ratio of 21.9x is below the industry average, indicating potential value for investors.

Competitive Landscape

Pro stress-test →

Gulf Pharmaceutical competes in the UAE pharmaceutical market with a diverse portfolio targeting major therapeutic segments including endocrinology, anti-infective, cardiovascular and gastroenterology. Competition includes regional and international pharma manufacturers serving GCC markets.

Industry Context

Gulf Pharmaceutical Industries P.S.C. operates in Pharmaceutical Manufacturing & Healthcare Products.

Key facts

Founded: 1980 · Headquarters: Ras Al Khaymah, UAE · Employees: 2,400

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Gulf Pharmaceutical Industries P.S.C..

  • Returned to profitability in 2025 with AED 166.7 million net income for 9M period
  • Strong liquidity position with short-term assets exceeding all liabilities and minimal debt-to-equity ratio
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2025Strategic Licensing Partnership with Dong A ST for innovative biotechnology product in MENA
  • February 2025Completed divestment of Zahrat Al Rawdah Pharmacies subsidiary
  • +2 moreTrack every material event for Gulf Pharmaceutical Industries P.S.C. as it happens. Explore monitoring →
Get alerted when Gulf Pharmaceutical Industries P.S.C. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Generic PharmaceuticalsCompeting regional pharma manufacturers in GCC markets→

Compare Gulf Pharmaceutical Industries P.S.C. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Gulf Pharmaceutical Industries P.S.C. operates in Pharmaceutical Manufacturing & Healthcare Products. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Manufacturing & Healthcare Products research →
NEW · MCP server

Ask your AI assistant about Gulf Pharmaceutical Industries P.S.C.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Gulf Pharmaceutical Industries P.S.C. and its top competitor on Cyborg Score”
“What did Gulf Pharmaceutical Industries P.S.C. do this quarter?”
“Is Gulf Pharmaceutical Industries P.S.C. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Gulf Pharmaceutical Industries P.S.C. do?+
Gulf Pharmaceutical Industries manufactures and sells medicines, injections, and consumer healthcare products with specialization in wound care, cardiovascular, diabetes solutions, and pain management. The company ope...
What is Gulf Pharmaceutical Industries P.S.C.'s Cyborg Score?+
Gulf Pharmaceutical Industries P.S.C. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Gulf Pharmaceutical Industries P.S.C.'s main competitors?+
Named competitors include Generic Pharmaceuticals. The full competitive landscape is in the AskCyborg report.
How can I get the full Gulf Pharmaceutical Industries P.S.C. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Gulf Pharmaceutical Industries P.S.C. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Gulf Pharmaceutical Industries P.S.C. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.